Drug Shortage Report for UROCIT-K

Last updated on 2022-02-23

Report ID 151908
Drug Identification Number 01914022
Brand name UROCIT-K
Common or Proper name Potassium Citrate Extended Release Tablets
Company Name MISSION PHARMACAL COMPANY
Market Status CANCELLED POST MARKET
Active Ingredient(s) POTASSIUM CITRATE
Strength(s) 540MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 100-ct
ATC code A12BA
ATC description POTASSIUM
Reason for shortage Other (Please describe in comments)
Anticipated start date 2021-12-17
Actual start date 2021-12-17
Estimated end date 2022-02-15
Actual end date 2022-02-22
Shortage status Resolved
Updated date 2022-02-23
Company comments Delay from label supplier.
Health Canada comments
Tier 3 Status No
Contact Address 8000 INTERSTATE HIGHWAY 10 WEST
SAN ANTONIO, TEXAS
UNITED STATES 78230
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2022-02-23 English Compare
v8 2022-02-22 French Compare
v7 2022-02-22 English Compare
v6 2022-01-31 French Compare
v5 2022-01-31 English Compare
v4 2022-01-03 French Compare
v3 2022-01-03 English Compare
v2 2021-12-28 French Compare
v1 2021-12-28 English Compare

Showing 1 to 9 of 9